Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037434191> ?p ?o ?g. }
- W3037434191 endingPage "111294" @default.
- W3037434191 startingPage "111294" @default.
- W3037434191 abstract "Type 2 diabetes mellitus (T2DM) is a global disease that poses a significant threat to public health. The incidence of both diabetes and dementia has increased simultaneously. Researchers have found that a large proportion of dementia patients have T2DM. In recent years, increasing evidence has demonstrated a link between cognitive decline and T2DM. Although the exact pathogenesis of cognitive impairment in T2DM is still unknown, current studies suggest that hyperglycemia, cerebrovascular disease, brain insulin resistance, and changes in γ-aminobutyric acid (GABAergic) neurons may mediate the association between T2DM and cognitive impairment. These potential mechanisms may become targets for the treatment of cognitive disorders in patients with T2DM. Glucagon-like peptide-1 (GLP-1), a widely used anti-diabetic drug, has been shown to not only effectively lower blood glucose but also improve neurological function. Previous research has confirmed that GLP-1 and its analogues are effective in the treatment of cognitive impairment in patients with T2DM. This review describes current evidence on the mechanisms underlying the association between T2DM and cognitive impairment. In particular, this review focuses on recent advances in GLP-1 and its analogues for the treatment of T2DM-related cognitive impairment." @default.
- W3037434191 created "2020-07-02" @default.
- W3037434191 creator A5006190358 @default.
- W3037434191 creator A5013944614 @default.
- W3037434191 creator A5014280534 @default.
- W3037434191 creator A5018863416 @default.
- W3037434191 creator A5030202096 @default.
- W3037434191 creator A5053140567 @default.
- W3037434191 creator A5073273338 @default.
- W3037434191 creator A5078326064 @default.
- W3037434191 date "2020-09-01" @default.
- W3037434191 modified "2023-09-22" @default.
- W3037434191 title "Potential roles of Glucagon-like peptide-1 and its analogues in cognitive impairment associated with type 2 diabetes mellitus" @default.
- W3037434191 cites W1136751452 @default.
- W3037434191 cites W1593904343 @default.
- W3037434191 cites W1650293197 @default.
- W3037434191 cites W1887630777 @default.
- W3037434191 cites W1970417130 @default.
- W3037434191 cites W1982795519 @default.
- W3037434191 cites W1983521829 @default.
- W3037434191 cites W1987038781 @default.
- W3037434191 cites W1997581405 @default.
- W3037434191 cites W1999366133 @default.
- W3037434191 cites W2009447734 @default.
- W3037434191 cites W2013343090 @default.
- W3037434191 cites W2016932677 @default.
- W3037434191 cites W2030609731 @default.
- W3037434191 cites W2043947032 @default.
- W3037434191 cites W2051503250 @default.
- W3037434191 cites W2062421477 @default.
- W3037434191 cites W2064156380 @default.
- W3037434191 cites W2067902437 @default.
- W3037434191 cites W2087447698 @default.
- W3037434191 cites W2087732718 @default.
- W3037434191 cites W2094880658 @default.
- W3037434191 cites W2097335530 @default.
- W3037434191 cites W2099751992 @default.
- W3037434191 cites W2106036385 @default.
- W3037434191 cites W2109659847 @default.
- W3037434191 cites W2121156580 @default.
- W3037434191 cites W2122914502 @default.
- W3037434191 cites W2124360636 @default.
- W3037434191 cites W2124386285 @default.
- W3037434191 cites W2132933127 @default.
- W3037434191 cites W2138258909 @default.
- W3037434191 cites W2145210854 @default.
- W3037434191 cites W2149663031 @default.
- W3037434191 cites W2152355721 @default.
- W3037434191 cites W2161146234 @default.
- W3037434191 cites W2266470476 @default.
- W3037434191 cites W2268192729 @default.
- W3037434191 cites W2288888153 @default.
- W3037434191 cites W2334014204 @default.
- W3037434191 cites W2342553225 @default.
- W3037434191 cites W2461216536 @default.
- W3037434191 cites W2497601590 @default.
- W3037434191 cites W2518609635 @default.
- W3037434191 cites W2602961020 @default.
- W3037434191 cites W2609925520 @default.
- W3037434191 cites W2621460425 @default.
- W3037434191 cites W2735546776 @default.
- W3037434191 cites W2773040321 @default.
- W3037434191 cites W2784879543 @default.
- W3037434191 cites W2790068096 @default.
- W3037434191 cites W2793413710 @default.
- W3037434191 cites W2793501551 @default.
- W3037434191 cites W2793678678 @default.
- W3037434191 cites W2798036616 @default.
- W3037434191 cites W2810882781 @default.
- W3037434191 cites W2884234047 @default.
- W3037434191 cites W2887383679 @default.
- W3037434191 cites W2887818584 @default.
- W3037434191 cites W2888761164 @default.
- W3037434191 cites W2891027425 @default.
- W3037434191 cites W2901090438 @default.
- W3037434191 cites W2914820845 @default.
- W3037434191 cites W2946242962 @default.
- W3037434191 cites W2946621727 @default.
- W3037434191 cites W2961954273 @default.
- W3037434191 cites W2964318626 @default.
- W3037434191 cites W2966966909 @default.
- W3037434191 cites W2969226456 @default.
- W3037434191 cites W2980881483 @default.
- W3037434191 cites W2983614893 @default.
- W3037434191 cites W824596218 @default.
- W3037434191 doi "https://doi.org/10.1016/j.mad.2020.111294" @default.
- W3037434191 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32585235" @default.
- W3037434191 hasPublicationYear "2020" @default.
- W3037434191 type Work @default.
- W3037434191 sameAs 3037434191 @default.
- W3037434191 citedByCount "5" @default.
- W3037434191 countsByYear W30374341912021 @default.
- W3037434191 countsByYear W30374341912022 @default.
- W3037434191 crossrefType "journal-article" @default.
- W3037434191 hasAuthorship W3037434191A5006190358 @default.
- W3037434191 hasAuthorship W3037434191A5013944614 @default.
- W3037434191 hasAuthorship W3037434191A5014280534 @default.
- W3037434191 hasAuthorship W3037434191A5018863416 @default.